 |
Altretamine |
|---|---|
| Trade Name | Hexalen |
| Orphan Indication | Advanced adenocarcinoma of the ovary |
| USA Market Approval | USA |
| USA Designation Date | 1984-02-09 00:00:00 |
| Sponsor | Medimmune Oncology, Inc.;One Tower Bridge, 100 Front St., Suite 400;West Conshohocken, Pennsylvania, 19428 |
